Latest News about RLFTF
Recent news which mentions RLFTF
Relief Therapeutics, NRx Pharma Settle Litigation Regarding COVID-19 Treatment Candidate
November 14, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
From Benzinga
From Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
January 13, 2022
From Benzinga
NRx Pharma Files Counterclaim Against Relief Therapeutics Over COVID-19 Candidate Rights
January 13, 2022
From Benzinga
From InvestorPlace
BYND Stock: 11 Things for Plant-Based Investors to Know About the KFC Beyond Meat ‘Fried Chicken’ News
January 05, 2022
From InvestorPlace
RLFTF Stock Alert: What Is Going on With Relief Therapeutics Today?
January 05, 2022
From InvestorPlace
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
December 14, 2021
From Benzinga
FDA Denies Breakthrough Tag For NRx Pharma's COVID-19 Candidate
November 24, 2021
From Benzinga
NRx Pharma Stock Nosedives As FDA Strikes Off Its COVID-19 Drug Hopeful
November 05, 2021
From Benzinga
Relief Therapeutics' Subsidiary Posts Early Data For Nasal Spray COVID-19 Treatment
October 27, 2021
Tickers
RLFTF
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Acer Therapeutics Stock Jumps As UCD Candidate Is Under FDA Review
October 06, 2021
From Benzinga
From InvestorPlace
Why NRX Pharmaceuticals (NRXP) Stock Is Moving Friday?
July 23, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.